Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2009 11:01

RNS Number : 2364W
Skyepharma PLC
24 July 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SKYEPHARMA PLC

GB00B3BFNB64

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 N/A

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

N/A 

An event changing the breakdown of voting rights

N/A 

Other (please specify):

N/A 

3. Full name of person(s) subject to the notification obligation:

 UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3.):

 UBS AG LONDON BRANCH

5. Date of the transaction and date on which the threshold is crossed or reached:

 22 JULY 2009

6. Date on which issuer notified:

 24 JULY 2009

7. Threshold(s) that is/are crossed or reached:

 6.07%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

 1,147,010

 1,147,010

 1,452,702

 1,452,702

 -

 6.07%

 -

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,452,702

 6.07%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 ESTEBAN FRANK/ALEXA KOENIG

15. Contact telephone number:

 +41 44 239 5476

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKZLBLKDBZBBD
Date   Source Headline
23rd Nov 200511:41 amRNSRule 8.3- Skyepharma plc
23rd Nov 200511:38 amRNSRule 8.3- Skyepharma Plc
23rd Nov 200511:34 amRNSRule 8.3- SkyePharma
22nd Nov 200511:55 amRNSRule 8.3- SkyePharma plc
22nd Nov 200511:36 amRNSRule 8.3- Skyepharma Plc
22nd Nov 200511:27 amRNSRule 8.3- Skyepharma plc
22nd Nov 200510:28 amRNSRule 8.3- Skyepharma
21st Nov 200512:02 pmRNSRule 8.3- SkyePharma plc
21st Nov 200511:39 amRNSRule 8.3- Skyepharma PLC
18th Nov 200512:06 pmRNSRule 8.3- SkyePharma plc
18th Nov 200511:34 amRNSRule 2.10 Announcement
18th Nov 200510:53 amRNSRule 8.3- Skyepharma plc
17th Nov 20056:02 pmRNSRule 2.10 Announcement
17th Nov 200512:10 pmRNSRule 8.3- SkyePharma plc
16th Nov 200512:09 pmRNSEPT Disclosure
16th Nov 200511:35 amRNSRule 8.3- Skyepharma plc
15th Nov 200512:01 pmRNSEPT Disclosure
15th Nov 200511:56 amRNSRule 8.1- SkyePharma Plc
14th Nov 20052:26 pmRNSRule 2.10 Announcement
14th Nov 20057:02 amRNSStrategic Review
10th Nov 20051:58 pmRNSNotification of Shares
8th Nov 20053:00 pmRNSPresentation at Conference
7th Nov 20052:12 pmRNSNotification of Shares
3rd Nov 20054:39 pmRNSDirector/PDMR Shareholding
3rd Nov 20059:17 amRNSPlacemnt of Rights Issue Rump
3rd Nov 20057:45 amRNSRights Issue
1st Nov 20054:33 pmRNSNotification of Shares
1st Nov 20057:00 amRNSJapanese Marketing Agreement
25th Oct 20054:32 pmRNSNotification of Shares
24th Oct 20051:17 pmRNSNotification of Shares
21st Oct 200511:34 amRNSNotification of Shares
19th Oct 20054:42 pmRNSNotification of Shares
18th Oct 200512:41 pmRNSNotification of Shares-Amend
18th Oct 20059:51 amRNSNotification of Shares
17th Oct 20052:08 pmRNSNotification of Shares
17th Oct 200512:43 pmRNSNotification of Shares
12th Oct 200511:23 amRNSFiling of Prospectus
6th Oct 20054:47 pmRNSNotification of Shares
6th Oct 200510:03 amRNSNotification of Shares
5th Oct 20053:38 pmRNSR & D Day Update
5th Oct 200512:14 pmRNSNotification of Shares
3rd Oct 20053:34 pmRNSHolding(s) in Company
3rd Oct 20053:30 pmRNSDirector/PDMR Shareholding
30th Sep 20052:42 pmRNSNotification of Shares
30th Sep 200510:05 amRNSNotification of Interests
28th Sep 20057:04 amRNSRights Issue
28th Sep 20057:04 amRNSInterim Results
8th Sep 20052:25 pmRNSNotice of Interims
2nd Sep 20053:31 pmRNSResults Date&Flutiform Update
31st Aug 20052:23 pmRNSNotification of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.